🔎 Trials Near Me

መነሻ › የእንቁላል ካንሰር › ጆርጂያ › Atlanta

በAtlanta፣ GA ለየእንቁላል ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየእንቁላል ካንሰር የሚደረጉ 29 ጥናቶች በAtlanta እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • Emory Saint Joseph's Hospital, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT07001748

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Winship Cancer Institute of Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06270706

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06465069

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Emory Winship Cancer Institute, Atlanta
እድሜ 19 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06586957

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Piedmont Healthcare, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT05051722

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Site 0108 - Emory University Hospital, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT05128825

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Winship Cancer Institute, Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07213804

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Winship Cancer Institute of Emory University ( Site 0037), Atlanta
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07318558

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Winship Cancer Institute At Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT07214779

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT06303505

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT06400472

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Winship Cancer Institute of Emory University ( Site 0086), Atlanta
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06824467

Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • Emory Saint Joseph's Hospital, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ27 ኦገስ 2026 · NCT06492070

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Emory University - Winship Cancer Institute, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ኦገስ 2026 · NCT06582017

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ26 ኦገስ 2026 · NCT05281471

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Winship Cancer Institute, Emory University, Atlanta
እድሜ 15 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04851119

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

ተሳታዮችን በመፈለግ ላይ
  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • እና 3 ተጨማሪ
እድሜ ከ35 እስከ 50 · ሴቶች · የተሻሻለው በ7 ኦገስ 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • እና 3 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ኦገስ 2026 · NCT06580314

Clinical Pre-screening Protocol for Ovarian Cancer

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Emory Winship Cancer Institute, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ30 ጁላይ 2026 · NCT03877796

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Winship Cancer Institute, Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ጁላይ 2026 · NCT05768139

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Winship Cancer Institute, Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT05377996

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • GSK Investigational Site, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ጁን 2026 · NCT04641247

Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
  • Emory University Hospital/Winship Cancer Institute, Atlanta
እድሜ 25 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ26 ሜይ 2026 · NCT06760507

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • USA10-0, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሜይ 2026 · NCT06953089

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Emory Winship Cancer Institute, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኤፕሪ 2026 · NCT05735080

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Winship Cancer Institute, Emory University, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ23 ዲሴም 2025 · NCT06690775

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, Atlanta
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

A Beta-only IL-2 ImmunoTherapY Study

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Emory - Winship Cancer Institute, Atlanta
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ጁላይ 2025 · NCT05086692

በሌሎች ከተሞች ለየእንቁላል ካንሰር የሚደረጉ ጥናቶች

በAtlanta ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።